⌘K

Login Start Free

Home/Filings/4/0000899243-21-025132

4//SEC Filing

RODEN MATTHEW 4

Accession 0000899243-21-025132

CIK 0001808865other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 8:18 PM ET

Size

5.3 KB

Accession

0000899243-21-025132

Insider Transaction Report

Form 4

Period: 2021-06-17

iTeos Therapeutics, Inc.ITOS

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-17+16,608→ 0 total
Exercise: $26.03Exp: 2031-06-17→ Common Stock (16,608 underlying)

Footnotes (1)

[F1]This stock option shall vest and become exercisable in full upon the earlier to occur of (a) June 17, 2022 or (b) the next annual meeting of the Issuer's stockholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1

filerCIK 0001828130

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 8:18 PM ET
Size: 5.3 KB

View on SEC.gov